Microcurrent Stimulation to Treat Macular Degeneration
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
This is an observational study in which data will be collected from a group of patients with retinal diseases such as Dry Macular Degeneration, RetinitisPigmentosa, and Stargardt's Disease, who have opted to receive Microcurrent Stimulation Therapy as an alternative treatment for their retinal condition.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
50 Years and older (Adult, Older Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Patients with retinal disease such as Age-Related Macular Degeneration, STargardt's Disease, and Retinitis Pigmentosa
Ability to provide written consent and comply with follow up visits
Age 40 years or older
ETDRS best corrected visual acuity better than 5 letters
History of Dry Age Relted Macular Degeneration; Retinitis Pigmentosa; Stargardt's disease
No Anti-VEGF treatments for at least 3 months prior to study
No new antioxidant/vitamin supplementation for at least 3 months prior to study
History of Non-Compliance with regular medical visits
Significant media opacities (exclude NS 4+) that may interfere with assessing visual acuity
Presence of pigment epithelial tears or rips
Known serious allergies to fluorescein dye
Presence of retinal neovascularization
Any treatment with an investigation agent in the past 30 days